Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 719,507 | 199,950 | 800,723 | 419,420 | 557,174 | 2,696,774 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 719,507 | 199,950 | 800,723 | 419,420 | 557,174 | 2,696,774 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 1,896,539 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 800,235 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 719,507 | 199,950 | 800,723 | 419,420 | 557,174 | 2,696,774 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 25,645 | 34,420 | 39,054 | 44,883 | 71,463 | 215,465 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 218 | 218 | ||||
| 11 | Total support. Add lines 7 through 10 | 2,914,759 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2020 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2020 |
(iii) Distributable Amount for 2020 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2020 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2020: | ||||
| a From 2015....... | ||||
| b From 2016....... | ||||
| c From 2017....... | ||||
| d From 2018....... | ||||
| e From 2019....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2020 distributable amount | ||||
|
i
Carryover from 2015 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2020 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2020 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2020, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2020. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2021. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2016..... | ||||
| b Excess from 2017..... | ||||
| c Excess from 2018..... | ||||
| d Excess from 2019..... | ||||
| e Excess from 2020..... | ||||
| Facts And Circumstances Test |
|---|
| THE FOLLOWING FACTS AND CIRCUMSTANCES ALSO WERE REPORTED TO COME TO A FINAL DETERMINATION THAT THE ORGANIZATION IS A PUBLIC CHARITY: 1.170A-9(E)(3)(II) ATTRACTION OF PUBLIC SUPPORT. PACHYONYCHIA CONGENITA (PC) IS AN ULTRA-RARE SKIN DISORDER WHICH CAUSES PAINFUL BLISTERS AND CALLUSES ON FEET AS WELL AS THICKENED NAILS, CYSTS, AND OTHER PAINFUL SYMPTOMS. THE ORGANIZATION'S PRIMARY GOALS HAVE BEEN (1) TO INTEREST LEADING SCIENTISTS AND PHYSICIANS WHO SPECIALIZE IN KERATIN DISORDERS IN RESEARCH FOR THE ULTRA-RARE DISORDER, PC, AND TO ESTABLISH COLLABORATION AMONG RESEARCHERS; (2) TO ESTABLISH AND MAINTAIN AN INTERNATIONAL PC PATIENT REGISTRY (IPCRR) AS A RESOURCE FOR SCIENTIFIC RESEARCH; AND (3) TO PROVIDE EDUCATION AND SUPPORT FOR PHYSICIANS, SCIENTISTS, AND PC PATIENTS AND THEIR FAMILIES WORLDWIDE. BY THEIR VERY NATURE, THESE TYPES OF ACTIVITIES HAVE THE POTENTIAL TO ATTRACT SUPPORT FROM GOVERNMENTAL UNITS AND PUBLIC CHARITIES ON A CONTINUOUS BASIS. AT NO TIME HAS THE ORGANIZATION CONDUCTED ACTIVITIES WHICH SERVE THE PERSONAL OR PRIVATE INTERESTS OF ITS FOUNDERS OR RELATED PARTIES. THE ORGANIZATION MAINTAINS A CONTINUOUS AND BONA FIDE PROGRAM FOR SOLICITATION OF FUNDS. BROCHURES REQUESTING DONATIONS ARE WIDELY DISTRIBUTED AT SCIENTIFIC, PATIENT SUPPORT, AND PUBLIC EVENTS. THESE BROCHURES ARE ALSO DISTRIBUTED THROUGH DIRECT MAILINGS TO PERSONAL AND PROFESSIONAL CONTACTS. GRANT APPLICATIONS HAVE BEEN MADE TO FOUNDATIONS AND OTHERS. 1.170A-9(E)(III) PERCENTAGE OF FINANCIAL SUPPORT. THE ORGANIZATION RECEIVED 27.45% OF ITS SUPPORT FROM PUBLIC SOURCES FROM 2016 TO 2020. 1.170A-9(E)(3)(IV) SOURCES OF SUPPORT. THE ORGANIZATION HAS RECEIVED ITS SUPPORT FROM INDIVIDUALS, BUSINESSES, AND FOUNDATIONS NOT RELATED TO THE ORGANIZATION THROUGH EITHER BUSINESS OR FAMILY RELATIONS. IN ADDITION TO DIRECT DONATIONS, MANY INDIVIDUALS HAVE DONATED TIME AND SERVICES TO ASSIST THE ORGANIZATION IN ITS EXEMPT PURPOSE. 1.170A-9(E)(3)(V) REPRESENTATIVE GOVERNING BODY. THE ORGANIZATION HAS THREE BOARDS THAT GOVERN ITS ACTIVITIES: 1. THE BOARD OF TRUSTEES DOES NOT REPRESENT THE PERSONAL OR PRIVATE INTERESTS OF A LIMITED NUMBER OF DONORS OR RELATED PERSONS. ALL BOARD MEMBERS SERVE WITHOUT COMPENSATION. MEMBERS OF THE BOARD HAVE SPECIAL KNOWLEDGE OR EXPERTISE TO ASSIST IN FULFILLING ITS EXEMPT PURPOSE. 2. THE MEDICAL AND SCIENTIFIC ADVISORY BOARD IS A VOLUNTEER BOARD CONSISTING OF 24 PHYSICIANS AND SCIENTISTS WHO HAVE A SPECIALTY IN DERMATOLOGICAL RESEARCH AND GENETICS, WITH AN EMPHASIS IN KERATIN DISORDERS. SOME MEMBERS OF THIS BOARD ARE IN CONTACT DAILY WITH THE ORGANIZATION REGARDING RESEARCH AND PATIENT CARE. MANY ARE IN CONTACT SEVERAL TIMES EACH MONTH. CONFERENCE CALLS ARE REGULARLY SCHEDULED WITH THE ENTIRE GROUP AND WITH SPECIAL SUB-GROUPS FOR PLANNING. THIS BOARD IS AVAILABLE FOR CONSULTATION REGARDING PATIENT CARE AND PATIENT NEEDS. 3. VOLUNTARY PATIENT ADVOCATES WORK THROUGH VARIOUS TECHNOLOGIES AND SOCIAL MEDIA, SUCH AS FACEBOOK, TO PROVIDE PATIENT OUTREACH AND PATIENT- TO-PATIENT SUPPORT. 1.170A-9(E)(3)(VI) AVAILABILITY OF PUBLIC FACILITIES OR SERVICES; PUBLIC PARTICIPATION IN PROGRAMS OR POLICIES. (A) THE FACT THAT AN ORGANIZATION IS THE TYPE WHICH GENERALLY PROVIDES FACILITIES OR SERVICES DIRECTLY FOR THE BENEFIT OF THE GENERAL PUBLIC...WILL BE CONSIDERED EVIDENCE THAT SUCH ORGANIZATION IS "PUBLICLY SUPPORTED." IN FEBRUARY 2004, THE ORGANIZATION ORGANIZED THE FIRST INTERNATIONAL PC CONFERENCE IN WHICH 23 OF THE LEADING KERATIN SPECIALISTS ATTENDED, INCLUDING MARIO CAPECCHI (WINNER OF THE 2007 NOBEL PRIZE FOR MEDICINE). AT THE MEETING, THE GROUP FORMED THE INTERNATIONAL PC CONSORTIUM (IPCC) TO ENCOURAGE COLLABORATION FOR PC RESEARCH. THERE ARE NOW SEVERAL HUNDRED EXPERTS WHO ARE ACTIVE MEMBERS OF THE IPCC AND EACH HAS AGREED TO COLLABORATE AND SHARE REAGENTS AND EXPERTISE TO ASSIST OTHER IPCC MEMBERS IN REGARD TO PC RESEARCH AND PATIENT CARE. THE MAJORITY OF THESE PARTICIPANTS REPRESENT NON-GOVERNMENTAL ORGANIZATIONS THAT SERVE MEMBERS OF A CHARITABLE CLASS IN THEIR HOME COUNTRIES. A LIST OF PARTICIPANTS CAN BE PROVIDED IF NEEDED. BEGINNING WITH THE 2004 SYMPOSIUM, THE ORGANIZATION HAS SPONSORED AN ANNUAL SCIENTIFIC MEETING EACH YEAR. THE ORGANIZATION ALSO PROVIDES EXPERTISE DIRECTLY FOR THE BENEFIT OF THE GENERAL PUBLIC BY RESPONDING TO DOZENS OF TELEPHONE, MAIL, AND INTERNET INQUIRIES EACH WEEK AT NO CHARGE FROM PUBLIC HEALTH OFFICIALS, PRACTITIONERS, AND MEMBERS OF THE GENERAL PUBLIC. IN MANY CASES, MEMBERS OF THE MEDICAL AND SCIENTIFIC ADVISORY BOARD WILL PROVIDE RESPONSES WHEN SPECIFIC SCIENTIFIC OR MEDICAL OPINIONS ARE NEEDED. THE IPCC HAS ORGANIZED A STEERING COMMITTEE TO DIRECT EFFORTS OF THE IPCC AND THREE WORKING TEAMS, INCLUDING (1) A RESEARCH TEAM CONDUCTING BASIC AND TRANSLATIONAL RESEARCH, (2) A DIAGNOSTICS AND GENETICS TEAM, AND (3) A PHYSICIANS NETWORK. EACH OF THESE TEAMS ACTIVELY PROVIDE PUBLIC SERVICE TO THOSE WITH PC AND MANY OTHER RELATED SKIN DISORDERS. (B) THE FACT THAT AN ORGANIZATION IS AN EDUCATION OR RESEARCH INSTITUTION WHICH REGULARLY PUBLISHES SCHOLARLY STUDIES...WILL ALSO BE CONSIDERED EVIDENCE THAT SUCH ORGANIZATION IS "PUBLICLY SUPPORTED." FROM 2004 TO 2016, THE ORGANIZATION'S BOARD MEMBERS AND VOLUNTEERS HAVE CONTRIBUTED TO OVER 90 SCHOLARLY STUDIES RELATED TO PC AND PC RESEARCH. PUBLICATIONS CAN BE PROVIDED FOR REVIEW IF NEEDED. MANY ARE AVAILABLE ONLINE AT HTTP://WWW.PACHYONYCHIA.ORG/RESEARCH-ARTICLES/. ALSO, IPCC NEWSLETTERS HAVE BEEN PUBLISHED EVERY QUARTER SINCE 2004. IN ADDITION, NUMEROUS PRESENTATIONS ON PC HAVE BEEN MADE BY BOARD MEMBERS AND VOLUNTEERS IN SCIENTIFIC MEETINGS AROUND THE WORLD. (C) SIMILARLY, THE FOLLOWING FACTORS WILL ALSO BE CONSIDERED EVIDENCE THAT AN ORGANIZATION IS "PUBLICLY SUPPORTED": (1) THE PARTICIPATION IN, OR SPONSORSHIP OF, PROGRAMS OF THE ORGANIZATION BY MEMBERS OF THE PUBLIC HAVING SPECIAL KNOWLEDGE OR EXPERTISE, PUBLIC OFFICIALS, OR CIVIC OR COMMUNITY LEADERS. SEE (A) ABOVE FOR A DESCRIPTION OF THE ORGANIZATION'S INTERNATIONAL SCIENTIFIC CONFERENCE FOR EXAMPLES OF PARTICIPATION IN, AND SPONSORSHIP OF, PROGRAMS OF THE ORGANIZATION BY MEMBERS OF THE PUBLIC HAVING SPECIAL KNOWLEDGE OR EXPERTISE, PUBLIC OFFICIALS, OR CIVIC OR COMMUNITY LEADERS. IN ADDITION, THE ORGANIZATION HAS SEVERAL OTHER ACTIVITIES WHICH DEMONSTRATE THIS BROAD PUBLIC SUPPORT: 1. PATIENT MEETINGS HAVE BEEN HELD IN THE FOLLOWING LOCATIONS: BOSTON, MA (2019) SALT LAKE CITY, UT (2004 & 2009, 2017) - HOSTED BY UNIVERSITY OF UTAH KANSAS CITY, MO (2004) - HOSTED BY F.I.R.S.T DUNDEE, SCOTLAND (2004 AND 2006) - HOSTED BY UNIVERSITY OF DUNDEE NIAGRA FALLS, ONTARIO (2005) PARK CITY, UT (2007) PITLOCHRY, SCOTLAND (2008) EDINBURGH, SCOTLAND (2010, 2012, 2014, 2016) PARIS, FRANCE (2010, 2012, 2014) PHILADELPHIA, PA (2011) SANTA CRUZ, CA (2013) NEWARK, NJ (2015) LONDON, ENGLAND (2018) (CO-SPONSORED BY PC PROJECT EUROPE) MORE THAN A DOZEN PHYSICIANS AND SCIENTISTS VOLUNTEER THEIR TIME AND PAY THEIR OWN EXPENSES TO ATTEND THE PATIENT SUPPORT MEETINGS. PATIENTS AND MANY OF THEIR FAMILY MEMBER ATTEND SUPPORT MEETINGS. THE MEETING LOCATION ALTERNATES EACH YEAR BETWEEN EUROPE AND THE UNITED STATES TO GIVE PATIENTS BROAD ACCESS TO INFORMATION AND SUPPORT. 2. THE INTERNATIONAL PC RESEARCH REGISTRY HAS RECEIVED INSTITUTIONAL REVIEW BOARD APPROVAL THROUGH THE WESTERN INSTITUTIONAL REVIEW BOARD (STUDY 2004/0468/1057496). IRB APPROVAL HAS BEEN RENEWED EACH YEAR. THIS IS THE ONLY ACTIVE REGISTRY FOR PC PATIENTS IN THE WORLD. THERE ARE NEARLY 2,200 PATIENTS REGISTERED. PC PATIENTS ARE REGISTERED FROM OVER 60 COUNTRIES. 1.170A-9(E)(3)(VII) ADDITIONAL FACTORS PERTINENT TO MEMBERSHIP. THE ORGANIZATION IS NOT A MEMBERSHIP ORGANIZATION. |
| Return Reference | Explanation |
|---|---|
| PART II, LINE 10 | OTHER INCOME 218 |
| PART II, LINE 17A | THE FOLLOWING FACTS AND CIRCUMSTANCES ALSO WERE REPORTED TO COME TO A FINAL DETERMINATION THAT THE ORGANIZATION IS A PUBLIC CHARITY: 1.170A-9(E)(3)(II) ATTRACTION OF PUBLIC SUPPORT. PACHYONYCHIA CONGENITA (PC) IS AN ULTRA-RARE SKIN DISORDER WHICH CAUSES PAINFUL BLISTERS AND CALLUSES ON FEET AS WELL AS THICKENED NAILS, CYSTS, AND OTHER PAINFUL SYMPTOMS. THE ORGANIZATION'S PRIMARY GOALS HAVE BEEN (1) TO INTEREST LEADING SCIENTISTS AND PHYSICIANS WHO SPECIALIZE IN KERATIN DISORDERS IN RESEARCH FOR THE ULTRA-RARE DISORDER, PC, AND TO ESTABLISH COLLABORATION AMONG RESEARCHERS; (2) TO ESTABLISH AND MAINTAIN AN INTERNATIONAL PC PATIENT REGISTRY (IPCRR) AS A RESOURCE FOR SCIENTIFIC RESEARCH; AND (3) TO PROVIDE EDUCATION AND SUPPORT FOR PHYSICIANS, SCIENTISTS, AND PC PATIENTS AND THEIR FAMILIES WORLDWIDE. BY THEIR VERY NATURE, THESE TYPES OF ACTIVITIES HAVE THE POTENTIAL TO ATTRACT SUPPORT FROM GOVERNMENTAL UNITS AND PUBLIC CHARITIES ON A CONTINUOUS BASIS. AT NO TIME HAS THE ORGANIZATION CONDUCTED ACTIVITIES WHICH SERVE THE PERSONAL OR PRIVATE INTERESTS OF ITS FOUNDERS OR RELATED PARTIES. THE ORGANIZATION MAINTAINS A CONTINUOUS AND BONA FIDE PROGRAM FOR SOLICITATION OF FUNDS. BROCHURES REQUESTING DONATIONS ARE WIDELY DISTRIBUTED AT SCIENTIFIC, PATIENT SUPPORT, AND PUBLIC EVENTS. THESE BROCHURES ARE ALSO DISTRIBUTED THROUGH DIRECT MAILINGS TO PERSONAL AND PROFESSIONAL CONTACTS. GRANT APPLICATIONS HAVE BEEN MADE TO FOUNDATIONS AND OTHERS. 1.170A-9(E)(III) PERCENTAGE OF FINANCIAL SUPPORT. THE ORGANIZATION RECEIVED 27.45% OF ITS SUPPORT FROM PUBLIC SOURCES FROM 2016 TO 2020. 1.170A-9(E)(3)(IV) SOURCES OF SUPPORT. THE ORGANIZATION HAS RECEIVED ITS SUPPORT FROM INDIVIDUALS, BUSINESSES, AND FOUNDATIONS NOT RELATED TO THE ORGANIZATION THROUGH EITHER BUSINESS OR FAMILY RELATIONS. IN ADDITION TO DIRECT DONATIONS, MANY INDIVIDUALS HAVE DONATED TIME AND SERVICES TO ASSIST THE ORGANIZATION IN ITS EXEMPT PURPOSE. 1.170A-9(E)(3)(V) REPRESENTATIVE GOVERNING BODY. THE ORGANIZATION HAS THREE BOARDS THAT GOVERN ITS ACTIVITIES: 1. THE BOARD OF TRUSTEES DOES NOT REPRESENT THE PERSONAL OR PRIVATE INTERESTS OF A LIMITED NUMBER OF DONORS OR RELATED PERSONS. ALL BOARD MEMBERS SERVE WITHOUT COMPENSATION. MEMBERS OF THE BOARD HAVE SPECIAL KNOWLEDGE OR EXPERTISE TO ASSIST IN FULFILLING ITS EXEMPT PURPOSE. 2. THE MEDICAL AND SCIENTIFIC ADVISORY BOARD IS A VOLUNTEER BOARD CONSISTING OF 24 PHYSICIANS AND SCIENTISTS WHO HAVE A SPECIALTY IN DERMATOLOGICAL RESEARCH AND GENETICS, WITH AN EMPHASIS IN KERATIN DISORDERS. SOME MEMBERS OF THIS BOARD ARE IN CONTACT DAILY WITH THE ORGANIZATION REGARDING RESEARCH AND PATIENT CARE. MANY ARE IN CONTACT SEVERAL TIMES EACH MONTH. CONFERENCE CALLS ARE REGULARLY SCHEDULED WITH THE ENTIRE GROUP AND WITH SPECIAL SUB-GROUPS FOR PLANNING. THIS BOARD IS AVAILABLE FOR CONSULTATION REGARDING PATIENT CARE AND PATIENT NEEDS. 3. VOLUNTARY PATIENT ADVOCATES WORK THROUGH VARIOUS TECHNOLOGIES AND SOCIAL MEDIA, SUCH AS FACEBOOK, TO PROVIDE PATIENT OUTREACH AND PATIENT- TO-PATIENT SUPPORT. 1.170A-9(E)(3)(VI) AVAILABILITY OF PUBLIC FACILITIES OR SERVICES; PUBLIC PARTICIPATION IN PROGRAMS OR POLICIES. (A) THE FACT THAT AN ORGANIZATION IS THE TYPE WHICH GENERALLY PROVIDES FACILITIES OR SERVICES DIRECTLY FOR THE BENEFIT OF THE GENERAL PUBLIC...WILL BE CONSIDERED EVIDENCE THAT SUCH ORGANIZATION IS "PUBLICLY SUPPORTED." IN FEBRUARY 2004, THE ORGANIZATION ORGANIZED THE FIRST INTERNATIONAL PC CONFERENCE IN WHICH 23 OF THE LEADING KERATIN SPECIALISTS ATTENDED, INCLUDING MARIO CAPECCHI (WINNER OF THE 2007 NOBEL PRIZE FOR MEDICINE). AT THE MEETING, THE GROUP FORMED THE INTERNATIONAL PC CONSORTIUM (IPCC) TO ENCOURAGE COLLABORATION FOR PC RESEARCH. THERE ARE NOW SEVERAL HUNDRED EXPERTS WHO ARE ACTIVE MEMBERS OF THE IPCC AND EACH HAS AGREED TO COLLABORATE AND SHARE REAGENTS AND EXPERTISE TO ASSIST OTHER IPCC MEMBERS IN REGARD TO PC RESEARCH AND PATIENT CARE. THE MAJORITY OF THESE PARTICIPANTS REPRESENT NON-GOVERNMENTAL ORGANIZATIONS THAT SERVE MEMBERS OF A CHARITABLE CLASS IN THEIR HOME COUNTRIES. A LIST OF PARTICIPANTS CAN BE PROVIDED IF NEEDED. BEGINNING WITH THE 2004 SYMPOSIUM, THE ORGANIZATION HAS SPONSORED AN ANNUAL SCIENTIFIC MEETING EACH YEAR. THE ORGANIZATION ALSO PROVIDES EXPERTISE DIRECTLY FOR THE BENEFIT OF THE GENERAL PUBLIC BY RESPONDING TO DOZENS OF TELEPHONE, MAIL, AND INTERNET INQUIRIES EACH WEEK AT NO CHARGE FROM PUBLIC HEALTH OFFICIALS, PRACTITIONERS, AND MEMBERS OF THE GENERAL PUBLIC. IN MANY CASES, MEMBERS OF THE MEDICAL AND SCIENTIFIC ADVISORY BOARD WILL PROVIDE RESPONSES WHEN SPECIFIC SCIENTIFIC OR MEDICAL OPINIONS ARE NEEDED. THE IPCC HAS ORGANIZED A STEERING COMMITTEE TO DIRECT EFFORTS OF THE IPCC AND THREE WORKING TEAMS, INCLUDING (1) A RESEARCH TEAM CONDUCTING BASIC AND TRANSLATIONAL RESEARCH, (2) A DIAGNOSTICS AND GENETICS TEAM, AND (3) A PHYSICIANS NETWORK. EACH OF THESE TEAMS ACTIVELY PROVIDE PUBLIC SERVICE TO THOSE WITH PC AND MANY OTHER RELATED SKIN DISORDERS. (B) THE FACT THAT AN ORGANIZATION IS AN EDUCATION OR RESEARCH INSTITUTION WHICH REGULARLY PUBLISHES SCHOLARLY STUDIES...WILL ALSO BE CONSIDERED EVIDENCE THAT SUCH ORGANIZATION IS "PUBLICLY SUPPORTED." FROM 2004 TO 2016, THE ORGANIZATION'S BOARD MEMBERS AND VOLUNTEERS HAVE CONTRIBUTED TO OVER 90 SCHOLARLY STUDIES RELATED TO PC AND PC RESEARCH. PUBLICATIONS CAN BE PROVIDED FOR REVIEW IF NEEDED. MANY ARE AVAILABLE ONLINE AT HTTP://WWW.PACHYONYCHIA.ORG/RESEARCH-ARTICLES/. ALSO, IPCC NEWSLETTERS HAVE BEEN PUBLISHED EVERY QUARTER SINCE 2004. IN ADDITION, NUMEROUS PRESENTATIONS ON PC HAVE BEEN MADE BY BOARD MEMBERS AND VOLUNTEERS IN SCIENTIFIC MEETINGS AROUND THE WORLD. (C) SIMILARLY, THE FOLLOWING FACTORS WILL ALSO BE CONSIDERED EVIDENCE THAT AN ORGANIZATION IS "PUBLICLY SUPPORTED": (1) THE PARTICIPATION IN, OR SPONSORSHIP OF, PROGRAMS OF THE ORGANIZATION BY MEMBERS OF THE PUBLIC HAVING SPECIAL KNOWLEDGE OR EXPERTISE, PUBLIC OFFICIALS, OR CIVIC OR COMMUNITY LEADERS. SEE (A) ABOVE FOR A DESCRIPTION OF THE ORGANIZATION'S INTERNATIONAL SCIENTIFIC CONFERENCE FOR EXAMPLES OF PARTICIPATION IN, AND SPONSORSHIP OF, PROGRAMS OF THE ORGANIZATION BY MEMBERS OF THE PUBLIC HAVING SPECIAL KNOWLEDGE OR EXPERTISE, PUBLIC OFFICIALS, OR CIVIC OR COMMUNITY LEADERS. IN ADDITION, THE ORGANIZATION HAS SEVERAL OTHER ACTIVITIES WHICH DEMONSTRATE THIS BROAD PUBLIC SUPPORT: 1. PATIENT MEETINGS HAVE BEEN HELD IN THE FOLLOWING LOCATIONS: BOSTON, MA (2019) SALT LAKE CITY, UT (2004 & 2009, 2017) - HOSTED BY UNIVERSITY OF UTAH KANSAS CITY, MO (2004) - HOSTED BY F.I.R.S.T DUNDEE, SCOTLAND (2004 AND 2006) - HOSTED BY UNIVERSITY OF DUNDEE NIAGRA FALLS, ONTARIO (2005) PARK CITY, UT (2007) PITLOCHRY, SCOTLAND (2008) EDINBURGH, SCOTLAND (2010, 2012, 2014, 2016) PARIS, FRANCE (2010, 2012, 2014) PHILADELPHIA, PA (2011) SANTA CRUZ, CA (2013) NEWARK, NJ (2015) LONDON, ENGLAND (2018) (CO-SPONSORED BY PC PROJECT EUROPE) MORE THAN A DOZEN PHYSICIANS AND SCIENTISTS VOLUNTEER THEIR TIME AND PAY THEIR OWN EXPENSES TO ATTEND THE PATIENT SUPPORT MEETINGS. PATIENTS AND MANY OF THEIR FAMILY MEMBER ATTEND SUPPORT MEETINGS. THE MEETING LOCATION ALTERNATES EACH YEAR BETWEEN EUROPE AND THE UNITED STATES TO GIVE PATIENTS BROAD ACCESS TO INFORMATION AND SUPPORT. 2. THE INTERNATIONAL PC RESEARCH REGISTRY HAS RECEIVED INSTITUTIONAL REVIEW BOARD APPROVAL THROUGH THE WESTERN INSTITUTIONAL REVIEW BOARD (STUDY 2004/0468/1057496). IRB APPROVAL HAS BEEN RENEWED EACH YEAR. THIS IS THE ONLY ACTIVE REGISTRY FOR PC PATIENTS IN THE WORLD. THERE ARE NEARLY 2,200 PATIENTS REGISTERED. PC PATIENTS ARE REGISTERED FROM OVER 60 COUNTRIES. 1.170A-9(E)(3)(VII) ADDITIONAL FACTORS PERTINENT TO MEMBERSHIP. THE ORGANIZATION IS NOT A MEMBERSHIP ORGANIZATION. |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990, PAGE 6, PART VI, LINE 11B | THE BOARD OF DIRECTORS REVIEWS A DRAFT OF THE FORM 990 BEFORE THE FORM IS FILED. A COPY OF THE FINALIZED TAX RETURN IS PROVIDED TO THE BOARD OF DIRECTORS EACH YEAR AFTER THE RETURN IS FILED. |
| FORM 990, PAGE 6, PART VI, LINE 12C | THE ORGANIZATION HAS A FORMAL CONFLICT OF INTEREST POLICY. THIS POLICY REQUIRES ANNUAL WRITTEN DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST BY ALL BOARD MEMBERS AND MANAGEMENT. CONFLICT OF INTEREST FORMS ARE REVIEWED ANNUALLY AT LEAST ANNUALLY BY THE EXECUTIVE DIRECTOR AND BOARD CHAIR. IF A CONFLICT IS DETERMINED TO EXIST, BOARD MEMBERS ARE RECUSED FROM VOTING ON TOPICS RELATED TO THE CONFLICT. |
| FORM 990, PAGE 6, PART VI, LINE 17 | MINNESOTA, MISSOURI, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, OHIO, OREGON, PENNSYLVANIA, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN |
| FORM 990, PAGE 6, PART VI, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST. |
| FORM 990, PART IX, LINE 11G | CLERICAN AND ADMINISTRATIVE 1,412 5,896 0 GENETIC TESTING 25,365 0 0 PROFESSIONAL SERVICE 2,933 0 0 TOTAL 29,710 5,896 0 |
| Software ID: | |
| Software Version: |